Английская Википедия:Corixa (company)
Шаблон:Short description Шаблон:RefimproveШаблон:One sourceШаблон:About Шаблон:Infobox company Corixa was a biotechnology/pharmaceutical company based in Seattle, Washington, involved in the development of immunotherapeutics to combat autoimmune diseases, infectious diseases, and cancer. It was founded in 1994. It operated a laboratory and production facility in Hamilton, Montana.
The name Corixa comes from the true bug (Insecta: Hemiptera: Heteroptera) genus Corixa (family Corixidae, Water boatman), described by Geoffroy, in 1762.Шаблон:Citation needed
On 12 July 2005Шаблон:Citation needed, the European pharmaceuticals giant GlaxoSmithKline completed the acquisition of Corixa.[1] GSK had formerly made use of the Corixa's MPL (Monophosphoryl lipid A, a derivative of the lipid A molecule), an adjuvant in some of their vaccines.
On 31 March 2006, Corixa's doors closed after over 11 years in business.Шаблон:Citation needed
External links
References
- Английская Википедия
- Biotechnology companies of the United States
- Defunct companies based in Seattle
- Pharmaceutical companies established in 1994
- Biotechnology companies established in 1994
- Biotechnology companies disestablished in 2006
- 1994 establishments in Washington (state)
- 2005 mergers and acquisitions
- 2006 disestablishments in Washington (state)
- Pharmaceutical companies disestablished in 2006
- GSK plc
- Страницы, где используется шаблон "Навигационная таблица/Телепорт"
- Страницы с телепортом
- Википедия
- Статья из Википедии
- Статья из Английской Википедии
